A recent review in KI May 2010 Issue discussed the role of both interferon Aplha and Beta interferon in the role of kidney inflammation. Both of these play a major role in anti viral and auto immunity but their role in the kidney is unknown. Few points made by this review that were fascinating and shed some thought for research
1. All cells produce Type 1 interferons during viral infections but no data in renal cells
2. Type 1 interferons are also central mediators of SLE. Studies are on going to treat lupus with IFN gamma neutralizing antibodies
3. What about in HIVAN, the most widely studied virus and the kidney? Only one study reported increased intrarenal IFN-gamma production in human HIVAN biopsies compared with non HIV FSGS. This local release is probably what we see as tubuloreticular inclusions in HIVAN biopsies.
4. No data exists in Polyomavirus and such inclusions bodies.
5. Extrarenal viral infections like Hep C can trigger an immune complex GN with increased IFN-gamma production. What about in other immune complex diseases, some virus instigates an IFN response and triggers IgA and MPGN, no one knows.
6. IFN -alpha has been identified now as a central mediator in lupus. Hence the similarities with viral infections in terms of symptoms such as fever, athralgias might be interferon effect.
7. One way we use to figure out if the membranous or the kidney disease is idiopathic vs lupus is the presence of tubuloreticular bodies( hence an interferon effect)
8. So in summary, little is known about the immunomodulary role in renal inflammation. in some cases, its harmful and in some cases such as Hep C and Renal Cell, it helps. The authors suggest that perhaps measuring urinary interferon levels might shed some light on the extent an interferon mediated process is involved.
Check out some other references
http://www.ncbi.nlm.nih.gov/pubmed/19773191
http://www.ncbi.nlm.nih.gov/pubmed/15320958
http://www.ncbi.nlm.nih.gov/pubmed/11256746
Saturday, May 8, 2010
Subscribe to:
Post Comments (Atom)
All Posts
-
▼
2010
(461)
-
▼
May
(48)
- Paricalcitol and CNI injury?
- Nephrology Crosswords
- TOPIC DISCUSSION: Shock wave lithotripsy for kidne...
- Role Playing in Transplant Teaching
- Role Playing in Transplant Teaching
- The SPLEEN in ANTIBODY MEDIATED REJECTION
- IN THE NEWS ---> FONT TRIAL
- IN THE NEWS ---> MCD vs FSGS
- Topic Discussion: Aldosterone
- Kidney Autotransplantation
- Risk of PTLD post transplant?
- The Online Transplant Center: Risk of PTLD post tr...
- Size and the Kidney from NephrologyWorld
- TOPIC DISCUSSION: Hyperammonemia and the Nephrologist
- Cellcept vs Myfortic? any difference!!
- EVEROLIMUS FOR KIDNEY TRANSPLANTS
- CLINICAL CASE 14 , ANSWER and SUMMARY
- TOPIC DISCUSSION: low K and low Mg??
- IN THE NEWS- VEGF and renal disease
- The effect of Mycophenolic Acid (MPA) on donor spe...
- The Extra Degrees!!!
- CONSULT ROUNDS: CONTRAST and ESRD/CKD
- TOPIC DISCUSSION: PHEOCHROMOCYTOMA
- Rituximab for recurrent idiopathic Membranous GN
- CD4 T cell lymphopenia is bad!
- Nephrology Crosswords
- CONSULT ROUNDS: Peritonitis
- Drug coverage for transplant from Nephrologyworld ...
- Topic Discussion: ANCA Disease
- IN THE NEWS- AGE and NEPHROSCLEROSIS
- CMV in organ transplantation
- CLINICAL CASE 13
- IN THE NEWS: encapsulating peritoneal sclerosis
- Check out the Latest from the world of Pediatrics
- TOPIC DISCUSSION: Interferon and the kidney
- New-Onset Diabetes Linked to Post-Transplant Hypom...
- New News on Belatacept
- Paired Donor Exchange Programs
- Bortezemib and highly sensitized patients
- H1N1 and Transplantation
- Complement activation and Antibody mediated rejection
- ATC Conference highlights 2010
- CONSULT ROUNDS: Distal RTA
- Are Generics trustworthy?
- TOPIC DISCUSSION: METHANOL and TOXIC EFFECTS
- New-Onset Diabetes Linked to Post-Transplant Hypom...
- American Transplant Congress from ECU
- TOPIC DISCUSSION: Hypokalemia causing Hyponatremia
-
▼
May
(48)
No comments:
Post a Comment